Clinical Outcomes of People With Fabry Disease - ANZDATA Registry Study
- PMID: 34514210
- PMCID: PMC8418971
- DOI: 10.1016/j.ekir.2021.06.013
Clinical Outcomes of People With Fabry Disease - ANZDATA Registry Study
Erratum in
-
Corrigendum to Ng MS, Malacova E, Hurst C, David MC, Johnson DW, Mallett AJ. "Clinical Outcomes of People With Fabry Disease - ANZDATA Registry Study." Kidney Int Rep. 2021;6:2481-2485.Kidney Int Rep. 2022 Feb 10;7(3):664. doi: 10.1016/j.ekir.2022.02.006. eCollection 2022 Mar. Kidney Int Rep. 2022. PMID: 35257086 Free PMC article.
Keywords: Fabry disease; clinical outcomes; end-stage kidney disease; enzyme replacement therapy; kidney replacement therapy; kidney transplantation; patient outcomes; registries; risk factors; survival.
References
-
- Waldek S., Patel M.R., Banikazemi M. Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry. Genet Med. 2009;11:790–796. - PubMed
-
- Lidove O., West M.L., Pintos-Morell G. Effects of enzyme replacement therapy in Fabry disease—a comprehensive review of the medical literature. Gen Med. 2010;12:668–679. - PubMed
-
- Mignani R., Feriozzi S., Pisani A. Agalsidase therapy in patients with Fabry disease on renal replacement therapy: a nationwide study in Italy. Nephrol Dial Transplant. 2007;23:1628–1635. - PubMed
-
- Cybulla M., Walter K.N., Schwarting A. Kidney transplantation in patients with Fabry disease. Transpl Int. 2009;22:475–481. - PubMed
-
- Thadhani R., Wolf M., West M.L. Patients with Fabry disease on dialysis in the United States. Kidney Int. 2002;61:249–255. - PubMed
LinkOut - more resources
Full Text Sources